Lymphastat Liquid
Product Images NDC 44911-0740

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lymphastat (NDC 44911-0740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Energique, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lymphastat (Enrg125 Lymphastat 1oz 4 16 25)

This text provides information on a homeopathic medicine containing various active ingredients in each drop, along with their associated purposes. The medicine may temporarily relieve symptoms associated with viral and bacterial infections such as fever, cough, sore throat, and nasal congestion. It includes warnings regarding severe or persistent symptoms, advising consultation with a physician. The medicine is recommended for adults and children above 3 years old, with specific dosing instructions. It also highlights inactive ingredients, storage directions, and a disclaimer about traditional homeopathic practice versus FDA evaluation.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.